InvestorsObserver
×
News Home

Does T2 Biosystems Inc (TTOO) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, December 21, 2022 01:21 PM | InvestorsObserver Analysts

Mentioned in this article

Does T2 Biosystems Inc (TTOO) Have What it Takes to be in Your Portfolio Wednesday?

The 57 rating InvestorsObserver gives to T2 Biosystems Inc (TTOO) stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 81 percent of stocks in the Diagnostics & Research industry, TTOO’s 57 overall rating means the stock scores better than 57 percent of all stocks.

Overall Score - 57
TTOO has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on TTOO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 57 would rank higher than 57 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With T2 Biosystems Inc Stock Today?

T2 Biosystems Inc (TTOO) stock is trading at $1.28 as of 1:01 PM on Wednesday, Dec 21, a rise of $0.11, or 9.4% from the previous closing price of $1.17. The stock has traded between $1.12 and $1.32 so far today. Volume today is high. So far 275,496 shares have traded compared to average volume of 143,769 shares. Click Here to get the full Stock Report for T2 Biosystems Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App